News
Efficacy and Speed of Pain Relief in Rheumatoid Arthritis When Adding Baricitinib to Methotrexate
The phase III clinical trial RA-BEAM conducted in patients with rheumatoid arthritis (RA) inadequately controlled by methotrexate demonstrated the benefit of adding baricitinib or adalimumab compared to placebo in terms of reducing the number of swollen joints. However, baricitinib showed greater pain relief starting from week 1 compared to placebo and from week 2 compared to adalimumab. Thus, the recently published results of an analysis using the data from this study aimed to compare the proportion of patients who achieved certain pain…
Can NOACs 'Compete' with Well-Managed Warfarin Treatment? Retrospective Data from Swedish Registers
Documented Cardiovascular Benefit of Empagliflozin in New American Diabetes Treatment Guidelines
Does the Risk of Recurrence of Differentiated Thyroid Carcinoma Differ by Gender?
How trends in sports evolve among hemophiliacs and to what extent they are limited by their disease
Incidence of Glaucoma or Suspected Glaucoma Within the First Year Post-Lensectomy in Children and Treatment Approach to These Patients
Metformin in New European Guidelines for Treating Patients with Diabetes and Cardiovascular Disease
Another Positive Effect of Diosmin − Influence on Oxidative Stress
How to Choose the Ideal Venotonic or Vasoprotective – Which Properties Are Key?
The Role of Probiotics in the Prevention of Childhood Infections
Conferences
News from the world of medicine
All conferences
Popular this week
- Climbing Stairs Helps Prolong Life and Prevent Heart Disease
- A Cap Instead of a Brain Implant?
- Could Artificial Intelligence Help with Emergency Department Triage in the Future?
- Target blood pressure values in heart failure
- BENIGN DERMATOSIS OF PENIS